Category Archives : Allgemein

Home  >>  Allgemein

European Health Catapult winners named at EIT Health Summit

On Dezember 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für European Health Catapult winners named at EIT Health Summit

Expert jury picks top start-ups from the 21 finalists 06 December 2017 The European Health Catapult Competition reached its climax on 5 December at the EIT Health Summit in London, where a jury of experts announced the winning start-ups in the Medtech, Biotech and Digital Health categories. Following a year…

DKFZ: Immune cells predict therapy response in breast cancer

On Dezember 11, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Immune cells predict therapy response in breast cancer

When immune cells invade the tumor, this is usually considered a good sign because the body’s own immune system appears to be responding to the cancer. In the case of certain types of breast cancer immune cells, namely so-called tumor-infiltrating lymphocytes (TILs), these can determine survival rates and predict the…

BioMed X launches new conference format XSEED CON 2018 – Towards Next Generation Bioscience

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für BioMed X launches new conference format XSEED CON 2018 – Towards Next Generation Bioscience

Heidelberg, Germany, December 6th, 2017 – BioMed X announced today the launch of a new conference format XSEED CON 2018 – Towards Next Generation Bioscience. For the first time in the successful history of the BioMed X Innovation Center in Heidelberg, its new model based on global crowdsourcing and local…

EMBL: Takeda joins drug target discovery initiative

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: Takeda joins drug target discovery initiative

Takeda joins pioneering public-private drug discover collaboration Open Targets Takeda is a global, research and development-driven pharmaceutical company with expertise in oncology, gastroenterology (GI) and central nervous system (CNS) disease that will complement the offerings of GSK, Biogen, the Wellcome Trust Sanger Institute and the European Bioinformatics Institute (EMBL-EBI), and build…

DKFZ: Berlin-Brandenburg Academy Prize for Lena Maier-Hein

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Berlin-Brandenburg Academy Prize for Lena Maier-Hein

Lena Maier-Hein from the German Cancer Research Center (DKFZ) helps physicians get better vision during minimally-invasive surgery. Using novel methods of image analysis, she wants to provide additional image information for surgeons. Thus, they can better differentiate tumors from healthy tissue and execute safer surgical tumor therapies. Maier-Hein now receives…

Hochschultag 2017 der Hochschule Mannheim

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Hochschultag 2017 der Hochschule Mannheim

Am 30.11.2017 konnte der Rektor der Hochschule Mannheim, Prof. Dr.-Ing. Dieter Leonhard, rund 240 Gäste zum Hochschultag 2017 begrüßen. In seiner Ansprache stellte er die Digitalisierung und die damit verbundenen Transformationsprozesse in Wirtschaft und Gesellschaft in den Mittelpunkt seiner Ausführungen. Er machte deutlich, dass die Hochschulen vor großen Herausforderungen stehen,…

Roche: FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Roche: FDA approves Foundation Medicine’s FoundationOne CDx, the first pan-tumour comprehensive genomic profiling assay incorporating a broad range of companion diagnostics

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved FoundationOne CDx™, Foundation Medicine’s comprehensive companion diagnostic assay for personalised oncology care1. FoundationOne CDx supports physicians in clinical decision-making by providing a report that describes the unique genomic profile of the patient’s…

BGI AND HUMMINGBIRD DIAGNOSTICS SIGN MEMORANDUM OF UNDERSTANDING

On Dezember 7, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für BGI AND HUMMINGBIRD DIAGNOSTICS SIGN MEMORANDUM OF UNDERSTANDING

Collaboration in miRNA-based molecular diagnostic applications for neurodegenerative disorders SHENZHEN, HEIDELBERG, December 6, 2017 – BGI, one of the world’s leading genomics organisations, headquartered in Shenzhen, Guangdong, P. R. China, and Hummingbird Diagnostics GmbH, Heidelberg, Germany, an innovator in miRNA-based diagnostic tests from blood for early disease detection, today announced…

DKFZ: Protective human anti-malarial antibodies induced by natural parasite exposure.

On November 30, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Protective human anti-malarial antibodies induced by natural parasite exposure.

No effective vaccine exists to date against the tropical disease malaria. Scientists from the German Cancer Research Center (DKFZ) have now studied how the human immune system responds to natural infection by the malaria parasite. Analyzing individual immune cells, they discovered that the immune system produces antibodies that are protective…

EMBL: 2 EMBL researchers awarded prestigious ERC grants

On November 28, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: 2 EMBL researchers awarded prestigious ERC grants

Takashi Hiiragi and Lars Steinmetz received Advanced Grants from the European Research Council (ERC) Two EMBL group leaders have joined a long list of EMBL principle investigators to receive prestigious ERC grants to support research in their labs. Takashi Hiiragi, a group leader in the Developmental Biology Unit in Heidelberg…